Pharma and Biotech Leaders to Converge in Shanghai

Asia Pharma R&D Leaders 2010 Summit to Highlight Ever-expanding R&D Outsourcing and Partnership Opportunities for Pharma and Biotech

SHANGHAI, Nov. 9 /PRNewswire-Asia/ -- The pharma and biotech sectors are at a pivotal point in their evolution. The companies are facing significant pressure to change with thinning pipelines, skyrocketing R&D costs, calls for lower prices and a greater regulatory burden, these conditions together with the financial crisis have made the work of creating new drugs harder than ever. Big pharmaceutical companies are being forced to globalize their R&D operations, especially to emerging markets.

Under this background, leaders of pharma and biotech companies from around the world will gather in Shanghai on March 4-5, 2010 at Asia Pharma R&D Leaders 2010 for strategies to capitalize on the enormous opportunity the booming Asia Market provides.

This event focuses on the operational, regulatory, and strategic challenges of outsourcing your drug discovery work to Asia.

Hear from distinguished industry experts at Asia Pharma R&D Leaders 2010. Some of this year's highlighted topics include:

    -- Partnering for innovation in Asia, new collaboration opportunities with
       big pharma

       -- Laurent Bertin, Vice President, R&D External Innovation, Sanofi-
          Aventis
       -- Hans-Jochiam Bohm, Head of Global Chemistry, Hoffman La-Roche
       -- Daniel Grant, Head of Strategic Alliances, Pfizer Australia
       -- Pierre Desmons, Director, Head of Development Partnerships,
          GlaxoSmithKline Biologicals

    -- Regulatory updates in China and how FDA is making sure the quality of
       outsourced work

       -- Christopher Hickey, Country Director (China), U.S. Food and Drug
          Administration

    -- Successful stories of R&D operation management in Asia and Do's &
       Don'ts in outsourcing

       -- Steve Yang, Head of Research Asia Global R&D, Pfizer
       -- Lily Lee, Senior Vice President and Head of Pharmaceutical R&D Asia,
          Johnson and Johnson
       -- Li Chen, Chief Scientific Officer Roche R&D China
       -- Tony Zhang, Managing Director and Site Head of China, Eli Lilly
          Global R&D
       -- Samantha Du, CEO, Hutchison MediPharma
       -- Richard Wang, Director, Strategic Alliance and Collaboration for
          Asia, AstraZeneca
       -- Yoshiki Nishikawa, Director of Kobe Pharma Research Institute Nippon,
          Boehringer Ingelheim

Plus, the event sets up an effective platform for you to meet face to face with a variety of Asia's local CROs and leading clinical practitioners to discuss the specifics of your outsourcing requirements.

An international audience consisting of senior-level pharma and biotech executives from the R&D, clinical development, business development, global market access, licensing, and regulatory affairs functions will be in attendance. For the full program and list of companies scheduled to attend, please visit the event website at http://www.aprdl.com .

For more information on registration and sponsoring/exhibiting, please contact:

Daniel Chen

Tel: +86-21-3251-6110

Email: daniel.chen@globaleaders.com

SOURCE Global Leaders Institute